Fifty-year follow-up and Strampelli anterior chamber intraocular lens

The Strampelli anterior chamber intraocular lens was created in 1953, and was primarily used to treat myopia and aphakia. Due to the positioning of the lens, it was associated with a number of complications, and was later modified to decrease the rate of significant complications, including endothel...

Full description

Bibliographic Details
Main Authors: Oakley, Carmen L., Nigro, Matthew A., Vote, Brendan J.
Format: Article
Language:English
Published: German Medical Science GMS Publishing House 2015-09-01
Series:GMS Ophthalmology Cases
Online Access:http://www.egms.de/static/en/journals/oc/2015-5/oc000028.shtml
id doaj-55096b0cfd304d3eba1e8837a3cf6d2c
record_format Article
spelling doaj-55096b0cfd304d3eba1e8837a3cf6d2c2020-11-25T03:20:41ZengGerman Medical Science GMS Publishing HouseGMS Ophthalmology Cases2193-14962015-09-015Doc0610.3205/oc000028Fifty-year follow-up and Strampelli anterior chamber intraocular lensOakley, Carmen L.0Nigro, Matthew A.1Vote, Brendan J.2Tasmanian Eye Institute, Launceston, Tasmania, AustraliaTasmanian Eye Institute, Launceston, Tasmania, AustraliaTasmanian Eye Institute, Launceston, Tasmania, AustraliaThe Strampelli anterior chamber intraocular lens was created in 1953, and was primarily used to treat myopia and aphakia. Due to the positioning of the lens, it was associated with a number of complications, and was later modified to decrease the rate of significant complications, including endothelial cell loss. This paper describes a 62-year-old man, who has had a Strampelli intraocular lens (IOL) in situ for 52 years, with relatively few complications. The case provides a framework for reflection on the significant advances in the development of IOLs since the Strampelli era.The Strampelli anterior chamber intraocular lens was created in 1953, and was primarily used to treat myopia and aphakia. Due to the positioning of the lens, it was associated with a number of complications, and was later modified to decrease the rate of significant complications, including endothelial cell loss. This paper describes a 62-year-old man, who has had a Strampelli intraocular lens (IOL) in situ for 52 years, with relatively few complications. The case provides a framework for reflection on the significant advances in the development of IOLs since the Strampelli era.http://www.egms.de/static/en/journals/oc/2015-5/oc000028.shtml
collection DOAJ
language English
format Article
sources DOAJ
author Oakley, Carmen L.
Nigro, Matthew A.
Vote, Brendan J.
spellingShingle Oakley, Carmen L.
Nigro, Matthew A.
Vote, Brendan J.
Fifty-year follow-up and Strampelli anterior chamber intraocular lens
GMS Ophthalmology Cases
author_facet Oakley, Carmen L.
Nigro, Matthew A.
Vote, Brendan J.
author_sort Oakley, Carmen L.
title Fifty-year follow-up and Strampelli anterior chamber intraocular lens
title_short Fifty-year follow-up and Strampelli anterior chamber intraocular lens
title_full Fifty-year follow-up and Strampelli anterior chamber intraocular lens
title_fullStr Fifty-year follow-up and Strampelli anterior chamber intraocular lens
title_full_unstemmed Fifty-year follow-up and Strampelli anterior chamber intraocular lens
title_sort fifty-year follow-up and strampelli anterior chamber intraocular lens
publisher German Medical Science GMS Publishing House
series GMS Ophthalmology Cases
issn 2193-1496
publishDate 2015-09-01
description The Strampelli anterior chamber intraocular lens was created in 1953, and was primarily used to treat myopia and aphakia. Due to the positioning of the lens, it was associated with a number of complications, and was later modified to decrease the rate of significant complications, including endothelial cell loss. This paper describes a 62-year-old man, who has had a Strampelli intraocular lens (IOL) in situ for 52 years, with relatively few complications. The case provides a framework for reflection on the significant advances in the development of IOLs since the Strampelli era.The Strampelli anterior chamber intraocular lens was created in 1953, and was primarily used to treat myopia and aphakia. Due to the positioning of the lens, it was associated with a number of complications, and was later modified to decrease the rate of significant complications, including endothelial cell loss. This paper describes a 62-year-old man, who has had a Strampelli intraocular lens (IOL) in situ for 52 years, with relatively few complications. The case provides a framework for reflection on the significant advances in the development of IOLs since the Strampelli era.
url http://www.egms.de/static/en/journals/oc/2015-5/oc000028.shtml
work_keys_str_mv AT oakleycarmenl fiftyyearfollowupandstrampellianteriorchamberintraocularlens
AT nigromatthewa fiftyyearfollowupandstrampellianteriorchamberintraocularlens
AT votebrendanj fiftyyearfollowupandstrampellianteriorchamberintraocularlens
_version_ 1724617237364473856